Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT04703686Phase 2Completed
Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy
Diffuse Large B-Cell Lymphoma RefractoryRefractory Indolent Adult Non-Hodgkin LymphomaRefractory Mantle Cell Lymphoma+2 more
StudychairStart date: 2021-03-30

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Pierre Sesques, MD

Lymphoma Study Association

Similar
1 trials

Shared therapeutic areas:

Diffuse Large B-Cell Lymphoma RefractoryRefractory Indolent Adult Non-Hodgkin LymphomaRefractory Mantle Cell Lymphoma+2 more

Worked with same sponsors:

The Lymphoma Academic Research Organisation
Collaborated on 1 trial
Similarity Score54%

Mazyar Shadman

Fred Hutch/University of Washington Cancer Consortium

Related
3 trials

Shared therapeutic areas:

Refractory Mantle Cell LymphomaRefractory Transformed B-Cell Non-Hodgkin Lymphoma
Similarity Score12%

Stephen E Spurgeon

OHSU Knight Cancer Institute

Related
5 trials

Shared therapeutic areas:

Refractory Mantle Cell Lymphoma
Similarity Score6%

Geoffrey Shouse

City of Hope Medical Center

Related
3 trials

Shared therapeutic areas:

Refractory Mantle Cell Lymphoma
Similarity Score6%

Ariela Noy

AIDS Malignancy Consortium

Related
2 trials

Shared therapeutic areas:

Refractory Transformed B-Cell Non-Hodgkin Lymphoma
Similarity Score6%

Stephen D. Smith

Fred Hutch/University of Washington Cancer Consortium

Related
3 trials

Shared therapeutic areas:

Refractory Mantle Cell Lymphoma
Similarity Score6%

Alex F Herrera

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Refractory Transformed B-Cell Non-Hodgkin Lymphoma
Similarity Score6%

Ajay Gopal

Fred Hutch/University of Washington Cancer Consortium

Related
8 trials

Shared therapeutic areas:

Refractory Mantle Cell Lymphoma
Similarity Score6%

Elizabeth Budde

City of Hope Medical Center

Related
2 trials

Shared therapeutic areas:

Refractory Mantle Cell Lymphoma
Similarity Score6%

Tycel J Phillips

City of Hope Medical Center

Related
3 trials

Shared therapeutic areas:

Refractory Mantle Cell Lymphoma
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04703686Phase 2StudyChair

Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy

Diffuse Large B-Cell Lymphoma RefractoryRefractory Indolent Adult Non-Hodgkin LymphomaRefractory Mantle Cell Lymphoma+2 more
Completed

All 1 trials loaded